Amylyx Pharmaceuticals, Inc. Common Stock AMLX
$29.49
-2.16%
at last close
Analyst Consensus
- Consensus Rating
- Buy (7 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $38.86
- Implied Upside
- +31.8%
- Price Target Range
- $19.00 – $57.00
- Analysts (12 mo)
- 7
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-27 | GuggenheimSeamus Fernandez |
Maintains | Buy | $55 → $57 |
| 2026-08-19 | MizuhoGraig Suvannavejh |
Maintains | Outperform | $30 → $42 |
| 2026-08-19 | GuggenheimSeamus Fernandez |
Maintains | Buy | $40 → $55 |
| 2026-08-19 | BairdJoel Beatty |
Maintains | Outperform | $28 → $52 |
| 2026-08-18 | HC Wainwright & Co.Andrew S. Fein |
Maintains | Buy | $34 → $55 |
| 2026-08-17 | MizuhoGraig Suvannavejh |
Maintains | Outperform | $24 → $30 |
| 2026-08-03 | CitigroupGeoff Meacham |
Maintains | Buy | $20 → $26 |
| 2026-07-20 | MizuhoGraig Suvannavejh |
Maintains | Outperform | $21 → $24 |
| 2026-06-25 | GuggenheimSeamus Fernandez |
Maintains | Buy | $30 → $40 |
| 2026-04-28 | MizuhoGraig Suvannavejh |
Maintains | Outperform | $19 → $21 |
| 2026-03-25 | HC Wainwright & Co.Andrew S. Fein |
Reiterates | Buy | $34 |
| 2026-03-19 | GuggenheimSeamus Fernandez |
Maintains | Buy | $25 → $30 |
| 2026-03-04 | HC Wainwright & Co.Andrew S. Fein |
Maintains | Buy | $28 → $34 |
| 2026-03-03 | StifelJames Condulis |
Initiates coverage on | Buy | $21 |
| 2026-02-20 | B of A SecuritiesGeoff Meacham |
Maintains | Buy | $15 → $19 |
| 2026-02-10 | HC Wainwright & Co.Andrew S. Fein |
Maintains | Buy | $20 → $28 |
| 2025-11-07 | HC Wainwright & Co.Andrew Fein |
Maintains | Buy | $16 → $20 |
| 2025-10-17 | CitigroupGeoff Meacham |
Maintains | Buy | $12 → $20 |
| 2025-10-16 | BairdJoel Beatty |
Maintains | Outperform | $10 → $19 |
| 2025-10-03 | B of A SecuritiesGeoff Meacham |
Maintains | Buy | $14 → $16 |
| 2025-09-16 | Goldman SachsCorinne Johnson |
Maintains | Buy | $10 → $20 |
| 2025-09-15 | GuggenheimSeamus Fernandez |
Maintains | Buy | $17 → $25 |
| 2025-08-28 | B of A SecuritiesGeoff Meacham |
Maintains | Buy | $10 → $14 |
| 2025-07-10 | Goldman SachsCorinne Johnson |
Reinstates | Buy | $10 |
| 2025-06-24 | GuggenheimSeamus Fernandez |
Initiates coverage on | Buy | $17 |
| 2025-06-17 | CitigroupGeoff Meacham |
Initiates coverage on | Buy | $12 |
| 2025-05-14 | MizuhoGraig Suvannavejh |
Maintains | Outperform | $7 → $8 |
| 2025-05-09 | HC Wainwright & Co.Andrew Fein |
Maintains | Buy | $12 → $16 |
| 2025-05-07 | Leerink PartnersMarc Goodman |
Upgrades | Market perform → Outperform | $4 → $10 |
| 2025-04-07 | MizuhoGraig Suvannavejh |
Upgrades | Neutral → Outperform | $3 → $7 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $29.49
- Market Cap
- $3.76 billion
- 52-Week Range
- $8.47 – $41.14
- Average Volume
- 3.03 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.